Dilated Cardiomyopathy in Borzoi

Learn about Dilated Cardiomyopathy in Borzoi. Risk level: medium. Onset: adult. Hereditary condition. Comprehensive guide to symptoms, diagnosis, treatment options, and prevention strategies.

Breed-Specific Risk Profile

Risk Levelmedium
Typical Onsetadult
HereditaryYes
Screening RecommendedYes

About Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM) is a primary myocardial disease characterized by dilation of the heart chambers and impaired systolic (contractile) function. The heart muscle becomes thin and weak, unable to pump blood effectively. It is the second most common heart disease in dogs, predominantly affecting large and giant breeds.

Category: Cardiovascular

Severity: Severe

Symptoms to Watch For in Your Borzoi

  • Exercise intolerance
  • Coughing (especially at night)
  • Rapid or labored breathing
  • Abdominal distension (ascites)
  • Weakness or collapse
  • Loss of appetite and weight loss
  • Irregular heart rhythm
  • Sudden death (especially in Dobermans)

Causes

Most cases are idiopathic with strong genetic predisposition. Known genetic mutations exist in some breeds (Doberman, Boxer). Nutritional deficiency (taurine, L-carnitine) causes reversible DCM in some breeds. Recent concerns about grain-free diets and DCM are under investigation.

Diagnosis

Echocardiography reveals chamber dilation and reduced fractional shortening (<25%). Holter monitoring detects arrhythmias. Chest radiographs show cardiomegaly and pulmonary edema. Cardiac biomarkers (NT-proBNP, troponin) aid early detection.

Treatment Options

Pimobendan (positive inotrope/vasodilator) is the cornerstone of therapy. ACE inhibitors, diuretics (furosemide, spironolactone), and antiarrhythmics as needed. Taurine/L-carnitine supplementation if deficient. Sodium-restricted diet.

Prevention for Borzoi

Genetic screening in predisposed breeds. Annual cardiac screening (echocardiography, Holter) for at-risk breeds. Ensuring adequate taurine in diet. Early detection through screening programs (Doberman occult DCM screening).

Prognosis

Guarded to poor once clinical signs develop. Median survival with treatment is 6-24 months depending on breed and stage at diagnosis. Dobermans have shorter survival times. Taurine-deficient DCM may be partially reversible.

Other Breeds Affected by Dilated Cardiomyopathy

Besides Borzoi, these breeds are also predisposed to Dilated Cardiomyopathy:

Frequently Asked Questions

Is Dilated Cardiomyopathy common in Borzoi?

Yes, Borzoi has a medium risk for Dilated Cardiomyopathy. This is a hereditary condition in this breed. Typical onset is during the adult stage.

What are the symptoms of Dilated Cardiomyopathy in Borzoi?

Common symptoms of Dilated Cardiomyopathy in Borzoi include: Exercise intolerance, Coughing (especially at night), Rapid or labored breathing, Abdominal distension (ascites), Weakness or collapse, Loss of appetite and weight loss. Watch for these signs and consult your veterinarian promptly.

How is Dilated Cardiomyopathy treated in Borzoi?

Pimobendan (positive inotrope/vasodilator) is the cornerstone of therapy. ACE inhibitors, diuretics (furosemide, spironolactone), and antiarrhythmics as needed. Taurine/L-carnitine supplementation if deficient. Sodium-restricted diet.

Can Dilated Cardiomyopathy be prevented in Borzoi?

Genetic screening in predisposed breeds. Annual cardiac screening (echocardiography, Holter) for at-risk breeds. Ensuring adequate taurine in diet. Early detection through screening programs (Doberman occult DCM screening).

Should I screen my Borzoi for Dilated Cardiomyopathy?

Yes, screening is recommended for Borzoi given their predisposition to Dilated Cardiomyopathy. Discuss appropriate screening schedules with your veterinarian.

Related Resources